SAM.govHR001126S0003
Open
Biological Technologies
- Response deadline
- Sep 30, 2026 Due in 29 days
- Date posted
- Oct 1, 2025
- Source
- Open notice
Description
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is soliciting proposals that leverage biological properties and processes to revolutionize our ability to protect the nation’s warfighters. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice.
Classifications
Documents (14)
- DownloadHR001126S0003_Attachment_I_Accelerated_Baseline_Model_Contract_Small_Business.pdf.pdf729 KB
- DownloadHR001126S0003_Attachment_J_Accelerated_Contract_Award_Option_Baseline_Model_Contract_Addendum.docx.docx25 KB
- DownloadHR001126S0003_Attachment_C_Volume_2_Template.docx.docx50 KB
- DownloadHR001126S0003.pdf.pdf272 KB
- DownloadHR001126S0003_Attachment_D_Streamlined_Cost_Proposal_Spreadsheet_V3.xlsx.xlsx563 KB
- DownloadHR001126S0003_Attachment_L_Accelerated_Award_Option_Model_OT_for_Research_v3.docx.docx86 KB
- DownloadHR001126S0003_Attachment_B_Volume_1_Template.docx.docx53 KB
- DownloadHR001126S0003_Attachment_K_Accelerated_Award_Option_Model_OT_for_Prototype_V3.docx.docx95 KB
- DownloadHR001126S0003_Attachment_M_Model_Cooperative_Agreement_V2.docx.docx97 KB
- DownloadHR001126S0003_Attachment_G_Accelerated_Award_Option_Election_and_Attestation_Form.docx.docx34 KB
- DownloadHR001126S0003_Attachment_E_Classified_Submission_Instructions.docx.docx31 KB
- DownloadHR001126S0003_Attachment_H_Accelerated_Baseline_Model_Contract_Large_Business.pdf.pdf727 KB
- DownloadHR001126S0003_Attachment_F_CUI_Guide.pdf.pdf316 KB
- DownloadHR001126S0003_Attachment_A_Abstract_Template.docx.docx41 KB
Contacts
Similar contracts
- Strand-Specific RNA-Sequencing ServicesMADue Sep 10, 2026
- Trusted Partner Program Coming Soon - UpdateNorth Carolina
- Custom Inducible Knockin MouseMarylandDue Sep 1, 2026
- Intent to Sole Source - Duke University MRI ServiceDue Aug 31, 2026
- Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo ValidationDue Sep 10, 2026
- Notice of Intent to Sole Source - Gut Microbiome DNA Sequencing ServicesPennsylvaniaDue Sep 1, 2026